SER-287
SERES-101
Phase 1 small_molecule completed
Quick answer
SER-287 for Ulcerative Colitis is a Phase 1 program (small_molecule) at Seres Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Seres Therapeutics
- Indication
- Ulcerative Colitis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed